Recalls & Warnings March 23, 2026 FDA Warns Consumers Not to Use ULTRA ADVANC3 Joint Supplements On February 26, 2026, the FDA warned consumers not to purchase or use ULTRA ADVANC3 and ULTRA ADVANC3 GOLD, products promoted for joint pain relief, because FDA testing found that they contain undeclared dexamethasone, diclofenac, and methocarbamol, which are not permitted in
Clinical pharmacology tests show that cagrilintide slows gastric emptying by about 70 minutes compared to the control group
Improves skin texture and clarity
That leaves the peptide supply chain vulnerable to bad actors, such as one peptide distributor who was sentenced for providing Americans with untested products sourced from unverified Chinese laboratories while falsely claiming adherence to U.S
The legal landscape is complex
In 2013, we developed a mathematical model corresponding to the above diagram (Ben-Shachar et al